Innovation
8 patent families (1 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 83 times.
| Year | Filings |
|---|---|
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 6 |
| 2025 | 5 |
| 2026 | 2 |
Social engagement
Social engagement: 4.6K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
6 investors on record; lead investors include Longitude Capital, Medicxi, RA Capital Management.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 33% |
| Private equity | 2 | 33% |
| Other / undisclosed | 2 | 33% |
Hiring activity
No recent openings observed
No roles tracked in the last 12 months
2 Aug 2025 · Clinical Scientist · Charlottesville
Based on job postings tracked across public sources.
Recent activity
5 Jun 2026
Product launch
RV-8451 oral GLP-1
4 Jun 2026
Event
Sachs Associates 2nd Annual Obesity & Cardiometabolic Innovation Forum
29 May 2026
Event
ADASciSessions